MetLife Investment Management’s Affirm AFRM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.27M Buy
15,571
+3,688
+31% +$241K 0.01% 1400
2026
Q1
$544K Sell
11,883
-497
-4% -$28.7K ﹤0.01% 1711
2025
Q4
$921K Buy
12,380
+351
+3% +$25.3K ﹤0.01% 1477
2025
Q3
$879K Buy
12,029
+297
+3% +$22.6K ﹤0.01% 1522
2025
Q2
$811K Buy
11,732
+7,072
+152% +$367K ﹤0.01% 1419
2025
Q1
$211K Buy
4,660
+106
+2% +$6.28K ﹤0.01% 2174
2024
Q4
$277K Buy
4,554
+499
+12% +$27.7K ﹤0.01% 2125
2024
Q3
$166K Sell
4,055
-25
-0.6% -$829 ﹤0.01% 2381
2024
Q2
$123K Sell
4,080
-311
-7% -$9.97K ﹤0.01% 2495
2024
Q1
$164K Buy
4,391
+10
+0.2% +$399 ﹤0.01% 2304
2023
Q4
$215K Sell
4,381
-19,669
-82% -$569K ﹤0.01% 2211
2023
Q3
$512K Buy
24,050
+19,742
+458% +$361K ﹤0.01% 1620
2023
Q2
$66K Sell
4,308
-273
-6% -$3.62K ﹤0.01% 2863
2023
Q1
$51.6K Buy
4,581
+85
+2% +$1.07K ﹤0.01% 2718
2022
Q4
$43.5K Buy
4,496
+845
+23% +$12.7K ﹤0.01% 2771
2022
Q3
$68.5K Sell
3,651
-47
-1% -$1.23K ﹤0.01% 2739
2022
Q2
$66.8K Buy
+3,698
New +$101K ﹤0.01% 2786

Other funds holding AFRM

MetLife Investment Management's AFRM Position: Q2 2026 in Review

MetLife Investment Management increased its Affirm (AFRM) stake by 31% in Q2 2026, buying an estimated $241K and bringing the position to 15,571 shares worth $1.27M. The position accounts for 0.01% of the portfolio, ranked #1400.

MetLife Investment Management first reported a position in AFRM in Q2 2022 and has held it in 17 quarters since. 662 funds tracked by Wall St. Rank hold AFRM as of Q2 2026.

  • MetLife Investment Management held 15,571 shares of Affirm worth $1.27M as of Q2 2026.
  • MetLife Investment Management bought 3,688 Affirm shares in Q2 2026, an estimated $241K.
  • Affirm made up 0.01% of MetLife Investment Management's portfolio in Q2 2026, its #1400 holding.
  • MetLife Investment Management first reported a position in Affirm in Q2 2022 and has held it in 17 quarters since.
  • 662 funds tracked by Wall St. Rank held Affirm as of Q2 2026.

Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.